The Asian, US, and European guidelines recommend a regimen of oral or intravenous injection of fluoropyrimidine combined with platinum as the palliative first-line chemotherapy for HER2-negative GC [27,28,29]. The gene discussed is ERBB2; the disease is gastric cancer.